GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ovation Science Inc (XCNQ:OVAT) » Definitions » EV-to-FCF

Ovation Science (XCNQ:OVAT) EV-to-FCF : -4.97 (As of May. 24, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ovation Science EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Ovation Science's Enterprise Value is C$1.67 Mil. Ovation Science's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.34 Mil. Therefore, Ovation Science's EV-to-FCF for today is -4.97.

The historical rank and industry rank for Ovation Science's EV-to-FCF or its related term are showing as below:

XCNQ:OVAT' s EV-to-FCF Range Over the Past 10 Years
Min: -30.65   Med: -3.88   Max: -0.52
Current: -4.97

During the past 7 years, the highest EV-to-FCF of Ovation Science was -0.52. The lowest was -30.65. And the median was -3.88.

XCNQ:OVAT's EV-to-FCF is ranked worse than
100% of 524 companies
in the Drug Manufacturers industry
Industry Median: 25.63 vs XCNQ:OVAT: -4.97

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-24), Ovation Science's stock price is C$0.045. Ovation Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.050. Therefore, Ovation Science's PE Ratio for today is At Loss.


Ovation Science EV-to-FCF Historical Data

The historical data trend for Ovation Science's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovation Science EV-to-FCF Chart

Ovation Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial -3.96 -5.85 -1.26 -1.11 -3.96

Ovation Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.11 -1.13 -1.21 -2.95 -3.96

Competitive Comparison of Ovation Science's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ovation Science's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ovation Science's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Ovation Science's EV-to-FCF falls into.



Ovation Science EV-to-FCF Calculation

Ovation Science's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1.669/-0.336
=-4.97

Ovation Science's current Enterprise Value is C$1.67 Mil.
Ovation Science's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ovation Science  (XCNQ:OVAT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Ovation Science's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.045/-0.050
=At Loss

Ovation Science's share price for today is C$0.045.
Ovation Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.050.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Ovation Science EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Ovation Science's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Ovation Science (XCNQ:OVAT) Business Description

Traded in Other Exchanges
Address
625 Howe Street, Suite 1140, Vancouver, BC, CAN, V6C 2T6
Ovation Science Inc is a Canada-based company mainly engaged in the business of sub-licensing rights to use Invisicare, a patented drug delivery technology used in topical and transdermal skin products containing hemp seed oil and cannabis products. The company also holds the right to manufacture, distribute, sell, market, sub-license and promote products formulated with Invisicare and containing cannabis products including cannabinoids, hemp seed oil and any synthetic derivatives of cannabis. It also develops formulas for skin product lines including topical and transdermal creams and lotions containing hemp seed oil and cannabis.
Executives
David K. Ryan Director

Ovation Science (XCNQ:OVAT) Headlines

No Headlines